Search Press releases Keywords From To 4 Dec 2020 Disposals of own shares Read More 20 Nov 2020 Disposals of own shares Read More 17 Nov 2020 UCB’s VIMPAT[®] (lacosamide) CV now approved by FDA in U.S. for primary generalized tonic-clonic seizures and expanded pediatric use for people living with epilepsy Read More 12 Nov 2020 UCB strengthens its gene therapy activities with additional pipeline programs, capabilities and platforms Read More 10 Nov 2020 Disposals of own shares Read More 6 Nov 2020 UCB Showcases Key Rheumatology Data at American College of Rheumatology Convergence 2020 Read More Pagination First page Previous page Previous … Page 53 Page 54 Page 55 Page 56 Current page 57 Page 58 Page 59 Page 60 Page 61 … Page 57 of 69 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
